Neuromyelitis Optica Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Neuromyelitis Optica Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-10Clinical Trial Update: Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder [Phase 2]
The phase 2 trial evaluating eculizumab for acute attacks of neuromyelitis optica spectrum disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-16Clinical Trial Update: A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders [Phase 2]
A Phase IIb trial of nabiximols for spasticity in neuromyelitis optica spectrum disorders has been withdrawn.